Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
Active, not recruiting · NCT04780516 · Registry updated 2025-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Active, not recruiting | Not stated | 2025-08-13 | NCT04780516 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barzilai Medical Center /ID# 229156 | Ashkelon | Israel | 1 |
| Duplicate_Kaplan Medical Center /ID# 226569 | Rehovot | Israel | 1 |
| HaEmek Medical Center /ID# 251040 | Afula | Israel | 1 |
| Leumit /ID# 252029 | Rehovot | Israel | 1 |
| Maccabi /ID# 246679 | Haifa | Israel | 1 |
| Rabin Medical Center /ID# 226568 | Petah Tikva | Israel | 1 |
| Shaare Zedek Medical Center /ID# 247319 | Jerusalem | Israel | 1 |
| Soroka University Medical Center /ID# 226570 | Beersheba | Israel | 1 |
| Tel Aviv Sourasky Medical Center /ID# 226564 | Tel Aviv | Israel | 1 |
| The Chaim Sheba Medical Center /ID# 226562 | Ramat Gan | Israel | 1 |
| ZIV Medical Center /ID# 226565 | Safed | Israel | 1 |